Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CME GROUP INC. Director's Dealing 2024

Mar 22, 2024

29871_dirs_2024-03-22_77dad99c-fcfd-4299-a221-1463bfe62cbc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CME GROUP INC. (CME)
CIK: 0001156375
Period of Report: 2024-01-31

Reporting Person: McCourt Timothy Francis (Sr MD Global Head Equity & FX)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-01-31 Common Stock Class A S 35 $206.775 Disposed 6447 Direct

Footnotes

F1: Represents a delinquent transaction for the sale of 35 shares on January 31, 2024.